Literature DB >> 25367869

Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits.

Yuping Gong1, Zhigang Wang1,2, Guifang Dong1, Yang Sun1, Xi Wang1, Yue Rong1, Maoping Li3, Dong Wang4, Haitao Ran1.   

Abstract

OBJECTIVE: To explore the antitumor effects of low-intensity focused ultrasound (LIFU) mediated localized drug delivery of adriamycin-microbubble-PLGA nanoparticle complexes on rabbits VX2 liver tumor.
METHODS: ADM-NMCs were prepared by covalent linking of ADM-PLGA nanoparticles (ADM-NPs) to the shell of the microbubbles. A fixed water bag filled with microbubbles was subjected to LIFU and non-focused ultrasound respectively, and the ultrasound images of which were recorded before and after ultrasonication. A total of 54 VX2 liver tumor-burdened rabbits were divided into six groups randomly, including control, ADM-NPs combined with LIFU, microbubbles combined with LIFU, ADM-NPs and microbubbles combined with LIFU, ADM-NMCs combined with LIFU and ADM-NMCs combined with Non-FUS. The tumor volume and volume inhibition rate (VIR) of tumor progression were calculated and compared. Apoptotic cells were labeled by terminal deoxyuridine nick end. Proliferating cell nuclear antigen was detected by immunohistochemistry. The median survival time of the animals were recorded and compared.
RESULTS: ADM-NMCs were successfully prepared with an average diameter of 1721 nm. The highest VIR and apoptotic index (AI) were found in the group of ADM-NMCs combined with LIFU while the lowest proliferating index (PI) was simultaneously observed in this group. The median survival time of the rabbits in the ADM-NMCs combined with LIFU group was the longest (71days) among all groups.
CONCLUSIONS: ADM-NMCs combined with LIFU could inhibit the rabbits VX2 liver tumor progress by delaying the tumor proliferation and accelerating apoptosis, which presents a novel process for liver tumor targeting chemotherapy.

Entities:  

Keywords:  ADM-NMCs; LIFU; PLGA nanoparticles; VX2 Liver cancer; microbubble

Mesh:

Substances:

Year:  2014        PMID: 25367869     DOI: 10.3109/10717544.2014.972528

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  7 in total

1.  Increasing Distribution of Drugs Released from In Situ Forming PLGA Implants Using Therapeutic Ultrasound.

Authors:  Chawan Manaspon; Christopher Hernandez; Pinunta Nittayacharn; Selva Jeganathan; Norased Nasongkla; Agata A Exner
Journal:  Ann Biomed Eng       Date:  2017-09-19       Impact factor: 3.934

2.  Apoptotic and genotoxic effects of low-intensity ultrasound on healthy and leukemic human peripheral mononuclear blood cells.

Authors:  Timur Saliev; Dinara Begimbetova; Dinara Baiskhanova; Danysh Abetov; Ulykbek Kairov; Charles P Gilman; Bakhyt Matkarimov; Katsuro Tachibana
Journal:  J Med Ultrason (2001)       Date:  2017-07-08       Impact factor: 1.314

3.  G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.

Authors:  Zhiping Yu; Yixuan Wang; Dan Xu; Lianhua Zhu; Ming Hu; Qiuli Liu; Weihua Lan; Jun Jiang; Luofu Wang
Journal:  Int J Nanomedicine       Date:  2020-01-08

4.  Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging.

Authors:  Jianxin Liu; Tingting Shang; Fengjuan Wang; Yang Cao; Lan Hao; JianLi Ren; Haitao Ran; Zhigang Wang; Pan Li; Zhiyu Du
Journal:  Int J Nanomedicine       Date:  2017-01-27

5.  Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy.

Authors:  Xueli Zhao; Wen Luo; Jing Hu; Lei Zuo; Jing Wang; Rui Hu; Bo Wang; Lei Xu; Jing Li; Meng Wu; Pan Li; Liwen Liu
Journal:  J Nanobiotechnology       Date:  2018-03-30       Impact factor: 10.435

6.  Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.

Authors:  Hongyun Zhao; Meng Wu; Leilei Zhu; Yi Tian; Mingxing Wu; Yizhen Li; Liming Deng; Wei Jiang; Wei Shen; Zhigang Wang; Zhechuan Mei; Pan Li; Haitao Ran; Zhiyi Zhou; Jianli Ren
Journal:  Theranostics       Date:  2018-02-14       Impact factor: 11.556

7.  Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities.

Authors:  Guilian Shi; Mingchuan Zhong; Fuli Ye; Xiaoming Zhang
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.